FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064547 [Registered on: 20/03/2024] Trial Registered Prospectively
Last Modified On: 14/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Studying effect of propofol and ketamine as induction agents in electro convulsive therapy in patients with depression. 
Scientific Title of Study   A comparative study of effectiveness of propofol and ketamine as induction agent for electro convulsive therapy in patient with severe depression. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kapuri Manasa 
Designation  Junior Resident(JR); Department of Anaesthesia  
Affiliation  Mahatma Gandhi Missions Medical College and Hospital 
Address  Dept of Anaesthesiology; 2nd floor, MGM Medical College and Hospital, N6, CIDCO, Aurangabad

Aurangabad
MAHARASHTRA
431003
India 
Phone  9381692170  
Fax    
Email  kapurimanasa.doc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sasturkar Vasanti Mukund 
Designation  MBBS,MD, Professor (dept. of anaesthesia, MGM Medical College and Hospital) 
Affiliation  MGM Medical College and Hospital 
Address  MGM Medical College and Hospital, N6, CIDCO, Aurangabad.

Aurangabad
MAHARASHTRA
431003
India 
Phone  9370668196  
Fax    
Email  vasantims@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Sasturkar Vasanti Mukund 
Designation  MBBS,MD, Professor (dept. of anaesthesia, MGM Medical College and Hospital) 
Affiliation  MGM Medical College and Hospital 
Address  MGM Medical College and Hospital, N6, CIDCO, Aurangabad.

Aurangabad
MAHARASHTRA
431003
India 
Phone  9370668196  
Fax    
Email  vasantims@rediffmail.com  
 
Source of Monetary or Material Support  
MGM Medical College and Hospital; N6, CIDCO; Aurangabad. 
 
Primary Sponsor  
Name  Kapuri Manasa 
Address  MGM Medical College and Hospital, N6, CIDCO, Aurangabd. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kapuri Manasa  MGM Medical College and Hospital  Department of Anaesthesiology; 2nd floor N6, CIDCO, Aurangabad.
Aurangabad
MAHARASHTRA 
9381692170

kapurimanasa.doc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Missions Ethics Committee for Research on Human Subjects   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F332||Major depressive disorder, recurrent severe without psychotic features,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Ketamine  Effectiveness of ketamine as induction agent in electro convulsive therapy in patients with severe depression duration of data collection -till 6 weeks after ect 
Comparator Agent  Propofol  Effectiveness of propofol as induction agent in ectro convulsive therapy in patients with severe depression duration of data collection-till 6 weeks after ect  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients of both sexes between age 18-65 years.
Patients with severe depressive disorder requiring electro convulsive therapy.
Patients with American Society of Anaesthesiology (ASA) physical status l & ll . 
 
ExclusionCriteria 
Details  Pregnant females and lactating mothers.
Patients on chronic opiate use such as tramadol.
Known allergies to study drugs.
Patients with hypertension, IHD and other heart diseases. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
A)
1)Mean blood pressure
2)Heart rate
3)Oxygen Saturation
B)
1)Spontaneous eye opening
2)Obeying verbal commands
C)
MADRS(Montgomery Asberg Depression Rating Scale) 
A)
2min before premedication
2min after induction
5min, 10min, 15min, 20min after giving shock and onset of seizures
B)
0min, 5min,10min, 15min post ect
C)
1st & 2nd week post ect 
 
Secondary Outcome  
Outcome  TimePoints 
Seizure duration  10 min after induction 
Incidence & severity of post ect agitation  15 min post ect 
Incidence & severity of post ect myalgia   6hrs & 12hrs post ect 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This clinical trail is a comparative study of propofol and ketamine as induction agents for electro convulsive therapy in patients with severe depression.
This is a double blinded study.
 
Close